Research & Reports

HK Innoen’s VP Song Geun‑seok was honored with the 3rd‑class Science and Technology Medal for 33 years of drug‑development R&D and innovation at the 2026 Technology Developer’s Day ceremony.

SK 바이오팜이 신경과학·항암 분야 글로벌 연구개발 인력을 확대하고, 신약 후보물질 발굴부터 글로벌 임상개발까지 전주기 R&D 체계를 강화했습니다.

KIMCo Foundation and the AI New Drug Research Institute will support the Ministry of SMEs’ 2026 Pharma‑Bio Venture Collaboration R&D project, covering 30 AI‑driven drug discovery tasks.

ArcGen Bio has been chosen as the lead research institute for the Ministry of SMEs and Startups' pharma‑bio venture collaboration project, receiving 30 billion KRW over three years, with LG Chem joining as a co‑research partner on a multi‑specific T‑cell engager immuno‑oncology drug.

Jongkundang has established NURATEON, a dedicated R&D subsidiary offering full‑cycle drug development services, from new formulations to DDS research.

Korea's pharma and biotech firms focus on July events including R&D disclosures, FDA submissions, clinical data and Q2 earnings, with analysts watching a potential sector re‑evaluation.

Verastem Oncology reports modest updated results for its approved first‑line metastatic pancreatic cancer regimen of avutometinib plus defactinib and will redirect primary R&D resources to other pipeline candidates.